Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Multiple sclerosis (MS) is a chronic disease that affects your central nervous system: your brain, spinal cord, and optic nerves. It can also affect your sexual function and desire. Research shows ...

The Engineering Science MS with a course focus in Data Science offers students a comprehensive education in big data and analysis. Students gain knowledge, expertise, and practical training in various ...

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...

BMNR Bitmine Immersion Technologies, Inc.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.